Teligent ROA 2010-2021 | TLGT
Current and historical return on assets (ROA) values for Teligent (TLGT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Teligent ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2021-06-30 |
$-0.09B |
$0.09B |
-78.46% |
| 2021-03-31 |
$-0.09B |
$0.10B |
-65.38% |
| 2020-12-31 |
$-0.12B |
$0.09B |
-74.50% |
| 2020-09-30 |
$-0.05B |
$0.19B |
-24.29% |
| 2020-06-30 |
$-0.05B |
$0.19B |
-27.18% |
| 2020-03-31 |
$-0.04B |
$0.19B |
-21.91% |
| 2019-12-31 |
$-0.03B |
$0.21B |
-12.66% |
| 2019-09-30 |
$-0.03B |
$0.20B |
-17.57% |
| 2019-06-30 |
$-0.03B |
$0.20B |
-16.08% |
| 2019-03-31 |
$-0.04B |
$0.19B |
-20.97% |
| 2018-12-31 |
$-0.04B |
$0.19B |
-19.15% |
| 2018-09-30 |
$-0.03B |
$0.19B |
-15.01% |
| 2018-06-30 |
$-0.03B |
$0.19B |
-17.67% |
| 2018-03-31 |
$-0.02B |
$0.18B |
-11.11% |
| 2017-12-31 |
$-0.02B |
$0.19B |
-7.84% |
| 2017-09-30 |
$-0.01B |
$0.19B |
-7.34% |
| 2017-06-30 |
$-0.01B |
$0.20B |
-4.23% |
| 2017-03-31 |
$-0.01B |
$0.19B |
-5.35% |
| 2016-12-31 |
$-0.01B |
$0.18B |
-6.43% |
| 2016-09-30 |
$-0.01B |
$0.19B |
-6.98% |
| 2016-06-30 |
$-0.01B |
$0.19B |
-6.98% |
| 2016-03-31 |
$-0.00B |
$0.19B |
-0.53% |
| 2015-12-31 |
$0.01B |
$0.18B |
3.67% |
| 2015-09-30 |
$0.02B |
$0.19B |
9.76% |
| 2015-06-30 |
$0.02B |
$0.20B |
13.75% |
| 2015-03-31 |
$0.01B |
$0.20B |
11.28% |
| 2014-12-31 |
$0.01B |
$0.20B |
8.70% |
| 2014-09-30 |
$-0.00B |
$0.05B |
-4.26% |
| 2014-06-30 |
$-0.00B |
$0.02B |
-6.90% |
| 2014-03-31 |
$-0.00B |
$0.02B |
-7.55% |
| 2013-12-31 |
$-0.00B |
$0.02B |
-8.16% |
| 2013-09-30 |
$-0.00B |
$0.01B |
-9.30% |
| 2013-06-30 |
$-0.00B |
$0.01B |
-20.51% |
| 2013-03-31 |
$-0.00B |
$0.01B |
-32.43% |
| 2012-12-31 |
$-0.00B |
$0.01B |
-45.71% |
| 2012-09-30 |
$-0.00B |
$0.01B |
-44.44% |
| 2012-06-30 |
$-0.00B |
$0.01B |
-31.58% |
| 2012-03-31 |
$-0.00B |
$0.01B |
-30.77% |
| 2011-12-31 |
$-0.00B |
$0.01B |
-29.27% |
| 2011-09-30 |
$-0.00B |
$0.01B |
-28.57% |
| 2011-06-30 |
$-0.01B |
$0.01B |
-52.63% |
| 2011-03-31 |
$-0.01B |
$0.01B |
-58.82% |
| 2010-12-31 |
$-0.01B |
$0.01B |
-66.67% |
| 2010-09-30 |
$-0.01B |
$0.01B |
-80.00% |
| 2010-06-30 |
$-0.00B |
$0.01B |
-61.54% |
| 2010-03-31 |
$-0.01B |
$0.01B |
-100.00% |
| 2009-12-31 |
$-0.01B |
$0.01B |
-103.23% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
